CI

CIGNA
D

CI

Arincen60/100B

CIGNA financials

Yes. CIGNA earned 5.99B USD of net income over the last twelve months, 2.1% of its revenue. It made a profit in 39 of its 41 fiscal years since 1985. Its last loss was in fiscal year 2002.

Revenue (TTM)
286.32B USD
Net income (TTM)
5.99B USD
Free cash flow (TTM)
8.27B USD
Cash and short-term investments
7.30B USD
Total debt
31.14B USD
Shareholders' equity
43.38B USD

Cash, debt and equity as of 30 Sept 2026.

CIGNA earnings

Next earnings · Q4 FY2026
EPS estimate
7.18 USD
Revenue estimate
74.90B USD
Last quarter · Q3 FY2026
EPS7.98Beat +6.1%Revenue73.68BBeat +1.4%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20278.53——+6.85%76.00B——+3.14%
Q2 FY20278.48——+9.05%73.82B——+3.00%
Q1 FY20278.35——+7.18%71.48B——+4.35%
Q4 FY20267.18——-11.14%74.90B——+3.35%
Q3 FY20267.527.98+6.12%+1.92%72.64B73.68B+1.44%+5.64%
Q2 FY20267.607.78+2.37%+8.06%70.14B71.67B+2.17%+6.60%
Q1 FY20267.607.79+2.50%+15.58%66.29B68.49B+3.32%+4.57%
Q4 FY20257.888.08+2.54%+21.69%70.31B72.47B+3.08%+10.28%
Q3 FY20257.647.83+2.49%+4.26%67.58B69.75B+3.21%+11.11%
Q2 FY20257.167.20+0.56%+7.14%62.91B67.23B+6.87%+11.17%

CIGNA growth and profitability

Full income statement
Revenue (TTM)
286.32B USD
Net income (TTM)
5.99B USD
Gross margin
10.26%
Operating margin
3.35%
Net margin
2.09%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY2025274.95B+11.26%5.96B+73.47%9.45%3.32%2.17%11.75B-5.76%
FY2024247.12B+26.56%3.43B-33.50%10.51%3.81%1.39%12.47B+3.30%
FY2023195.27B+8.17%5.16B-22.97%12.89%4.37%2.64%12.07B+4.80%
FY2022180.52B+3.70%6.70B+24.84%13.02%4.68%3.71%11.52B+3.89%
FY2021174.07B+8.52%5.37B-36.51%13.19%4.56%3.08%11.09B-2.48%

How CIGNA makes its money

Revenue274.95B 100.0%
Cost of revenue248.97B 90.5%
Gross profit25.99B 9.5%
Selling and administration14.00B 5.1%
Other operating expenses2.86B 1.0%
Operating income9.13B 3.3%
Tax1.35B 0.5%
Other expense1.83B 0.7%
Net income5.96B 2.2%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

CIGNA revenue breakdown

By product

FY2025
Evernorth: 83.2%Cigna Healthcare: 16.8%83.2%Evernorth16.8%Cigna Healthcare
SegmentRevenueShare of revenueChange on the year
Evernorth234.95B83.2%+18.6%
Cigna Healthcare47.41B16.8%-0.2%

By region

FY2024
100.0%United States
RegionRevenueShare of revenueChange on the year
United States241.56B100.0%+27.2%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY20259.60B8.39B
FY202410.36B8.96B
FY202311.81B10.24B
FY20228.66B7.36B
FY20217.19B6.04B
FY202010.35B9.26B
FY20199.49B8.44B
FY20183.77B3.24B
FY20174.09B3.62B
FY20164.03B3.57B

CIGNA financial health

Full balance sheet
Cash and short-term investments
7.30B USD
Total debt
31.14B USD
Net cash
-23.85B USD
Free cash flow (TTM)
8.27B USD
Current ratio
0.84
Debt to equity
0.72
Piotroski score
8 / 9
Altman Z-score
2.82

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20257.68B31.46B8.39B
FY20248.22B31.97B8.96B
FY20238.75B30.93B10.24B
FY20226.83B31.55B7.36B
FY20216.00B34.27B6.04B

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY2025157.92B116.05B41.71B
FY2024155.88B114.64B41.03B
FY2023152.76B106.41B46.22B
FY2022143.89B98.98B44.87B
FY2021154.89B107.71B47.11B
FY2020155.45B105.07B50.32B
FY2019155.77B110.40B45.34B
FY2018153.23B112.15B41.03B
FY201761.76B47.97B13.74B
FY201659.36B45.58B13.72B

CIGNA valuation

Price to earnings ratio (TTM)
12.94
Forward P/E (FY2026)
9.60
Price to sales (TTM)
0.27
Price to book
1.79
EV / EBITDA (TTM)
8.09

Capital structure

Market capitalization
77.49B USD
+
Total debt
31.14B USD
−
Cash and short-term investments
7.30B USD
=
Enterprise value
101.34B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)7.99————
FY2027 (est.)8.837.99———
FY2026 (est.)9.608.83———
Now (TTM)12.948.930.271.798.09
FY202512.348.980.271.758.25
FY202422.5413.340.311.898.17
FY202317.0413.340.461.929.28
FY202215.3013.340.572.3111.23
FY202114.4511.000.451.659.63

CIGNA against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Elevance Health, CVS Health, Humana, Centene, UnitedHealth Group, and Molina Healthcare, the US Medical - Healthcare Plans companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Below its median12.9
    9.129.4
  • Gross marginLowest in 5 years9.5%
    9.5%13.2%
    Against its peers: 6 of 7Peers' median 14.2%
  • Operating marginLowest in 5 years3.3%
    3.3%4.7%
    Against its peers: 3 of 7Peers' median 2.2%
  • Net marginBelow its median2.2%
    1.4%3.7%
    Against its peers: 3 of 7Peers' median 1.0%
  • Return on equityAbove its median14.3%
    8.4%14.9%
    Against its peers: 1 of 7Peers' median 9.2%
  • Free cash flow marginLowest in 5 years3.1%
    3.1%5.2%
    Against its peers: 2 of 7Peers' median 1.8%
  • Revenue growthAbove its median11.3%
    3.7%26.6%
    Against its peers: 5 of 7Peers' median 11.8%
  • EPS growthHighest in 5 years82.9%
    -31.4%82.9%
    Against its peers: 1 of 7Peers' median -35.5%
  • Debt to EBITDAAt its median2.68×
    2.56×3.09×
    Against its peers: 1 of 6Peers' median 4.05×
  • Current ratioHighest in 5 years0.85
    0.730.85
    Against its peers: 4 of 7Peers' median 1.04

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

CIGNA dividends

Annual dividend
6.24 USD
Dividend yield (indicated)
2.12%
Payout ratio
34.11%
Years of dividend growth
6
Frequency
Quarterly
Next payment
1.56 USD
Next ex-dividend date
3 Dec 2026
Next payment date
17 Dec 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share6.045.604.924.484.000.040.040.040.040.04

CIGNA ownership

Institutions
91.21%
Institutional holders
1,770 (+44)
Free float
99.50%

Who owns the shares

Institutions 91.2% Others 8.8%
As of 30 Jun 2026

Shares free to trade

Free float 262.20M shares ·99.5% Closely held 1.30M shares ·0.5%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q3 20260325.29K38.08K
Q2 2026014221.37K416.22K
Q1 202602159.01K29.12K
Q4 20251110.51K11.64K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025265.95M265.95M-6.10%
FY2024280.29M283.22M-4.60%
FY2023296.88M296.88M-5.17%
FY2022313.07M313.07M-8.18%
FY2021337.96M340.97M-7.44%

Common questions about CIGNA's financials

Source: Financial Modeling Prep